Technical Review Panel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$9.2 billion for grants starting in 2024. 152 new grants will begin implementation this month, supporting more than 70 countries to continue their lifesaving work to end the three epidemics and build sustainable and climate-resilient systems for health over the 2024-2026 period.

The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$9.2 billion for grants starting in 2024. 152 new grants will begin implementation this month, supporting more than 70 countries to continue their lifesaving work to end the three epidemics and build sustainable and climate-resilient systems for health over the 2024-2026 period.

Submissions to the public art competition must be received by Jan. 4 at 11:59 P.M. MST via email.

Value for money – maximizing and sustaining equitable and quality health outputs, outcomes and impact for a given level of resources – is a key principle guiding Global Fund investments. While the concept has long been an integral part of the Global Fund’s operations, from Grant Cycle 6 (GC6) onwards applicants are encouraged to explicitly consider it from funding request development through grant closure.

The following resources relating to the 2023-2025 funding cycle have been updated to reflect recommendations made by the Technical Review Panel (TRP) during Window 2.